Elan Bechor

Title: Elan Bechor and Polygenic Risk Assessment for IVF

Introduction

Elan Bechor is an inventor based in New York, New York, and is associated with Myome, Inc. His work includes an invention applying polygenic risk scoring to in vitro fertilization (IVF), with the aim of estimating disease risk for embryos and potential children.

Latest Patents

Bechor is named on one patent, titled “Polygenic Risk Score for In Vitro Fertilization.” The disclosed methods construct an embryo’s genome using genetic variants, paternal and maternal haplotypes, and the probabilities that those haplotypes will be transmitted. A polygenic risk score is then assigned to the constructed genome and used to estimate disease risk. The methods also address identifying disease-causing variants or haplotypes inherited from either parent, estimating a range of disease risks for potential children of a mother and sperm donor, and assessing disease risk in an individual. Bechor’s reported portfolio includes 1 patent.

Career Highlights

Bechor’s listed work connects genetic risk assessment with reproductive medicine. The patent describes computational methods for combining inherited genetic information and transmission probabilities to support embryo and individual disease-risk estimates. He is associated with Myome, Inc.

Collaborations

Bechor’s listed coworkers include Akash Kumar and Kate M. Im. Their names are provided as professional collaborators, though specific roles or contributions to the patent are not stated in the supplied information.

Conclusion

Elan Bechor’s patent focuses on using polygenic risk scores and inherited genetic information to estimate disease risk in IVF embryos and potential children.